在使用Q-RUDAS的Quechua老年人群中神经认知障碍的流行率
Jonathan Zegarra-Valdivia1, Ruth Diana Mamani Quispe2, José Chinoapaza Turpo2
1Psychology Program, Faculty of Health Sciences, Universidad Cientifica del Sur, Lima 15842, Peru.
Brain sciences
|December 24, 2025
概括
罗兰普世痴呆症评估尺度 (Q-RUDAS) 的奎丘亚语版本有效地选了秘鲁土著成年人的认知障碍. 该研究发现,在这个人群中,轻度认知障碍 (MCI) 和痴呆症的患病率为9.52%.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 罗兰普世痴呆症评估尺度 (RUDAS) 是一个有效的认知查工具,用于识字和教育程度有限的个人.
- 该RUDAS已经为秘鲁的奎丘亚语说者 (Q-RUDAS) 进行了调整,以评估老年人的认知状态.
研究的目的:
- 估计秘鲁一个社会脆弱地区的奎丘亚语老年人中轻度认知障碍 (MCI) 和痴呆症的患病率.
- 在这个人群中使用奎丘亚语版本的罗兰普世痴呆症评估尺度 (Q-RUDAS) 进行认知查.
主要方法:
- 一项研究与来自秘鲁普诺的511名参与者进行了研究 (平均年龄为65.04岁,80.4%是女性).
- 收集了社会人口统计数据和Q-RUDAS分数;493名参与者在排除后完成了测试.
- Q-RUDAS被用于评估认知功能.
主要成果:
- Q-RUDAS得到了很好的理解,尽管视觉空间任务给超过50%的参与者带来了挑战.
- 平均Q-RUDAS得分为26.01±2.71. 这是一个很好的结果.
- 轻度认知障碍 (MCI) 和痴呆症联合的患病率为9.52% (8.3%的MCI,1.2%的痴呆症).
结论:
- 在Q-RUDAS展示了文化敏感性和实用性在确定认知障碍在土著人群中.
- 建议进行进一步的交叉验证研究,以提高奎丘亚语社区的诊断准确度.
更多相关视频
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
3.4K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.7K
相关概念视频
Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Cochran's Q Test
906
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
906
